Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT06171789
What this trial is testing

PRO1107 in Patients With Advanced Solid Tumors

Who this might be right for
Endometrial CancerOvarian CancerTriple Negative Breast Cancer+3 more
Genmab 33
Testing effectiveness (Phase 2)Active Not RecruitingNCT01885689
What this trial is testing

Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Leukemia in Remission, or Chronic Myelomonocytic Leukemia

Who this might be right for
Adult Acute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAdult Acute Myeloid Leukemia in Remission+4 more
City of Hope Medical Center
Testing effectiveness (Phase 2)UnknownNCT02525068
What this trial is testing

Enzalutamide in Combination With AZD5363 in Patients With mCRPC

Who this might be right for
Adenocarcinoma of the Prostate
Institute of Cancer Research, United Kingdom 136
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07780318
What this trial is testing

BL-M08D in Patients With Locally Advanced or Metastatic Digestive Tract Tumors and Other Solid Tumors

Who this might be right for
Gastrointestinal TumorsSolid Tumors
Sichuan Baili Pharmaceutical Co., Ltd. 60
Testing effectiveness (Phase 2)Ended earlyNCT01133990
What this trial is testing

FOLFIRI Alone Versus FOLFIRI Plus Bevacizumab Versus FOLFIRI Plus E7820 as Second-Line Therapy in Patients With Locally Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Eisai Inc. 5
Early research (Phase 1)Study completedNCT01005797
What this trial is testing

Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers

Who this might be right for
Renal CancerNon Small Cell Lung Cancer (NSCLC)Soft Tissue Sarcoma
Medical University of South Carolina 38
Testing effectiveness (Phase 2)Study completedNCT00019097
What this trial is testing

Vaccine Therapy in Treating Patients With Multiple Myeloma

Who this might be right for
Stage II Multiple MyelomaStage III Multiple MyelomaRefractory Plasma Cell Neoplasm
National Cancer Institute (NCI)
Early research (Phase 1)Looking for participantsNCT04890613
What this trial is testing

Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation

Who this might be right for
Advanced Solid Tumor
Senhwa Biosciences, Inc. 52
Testing effectiveness (Phase 2)Ended earlyNCT04059484
What this trial is testing

Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer

Who this might be right for
Breast Cancer Metastatic
Sanofi 367
Testing effectiveness (Phase 2)Study completedNCT01265433
What this trial is testing

Galinpepimut-S (WT-1 Analog Peptide) Vaccine in Malignant Pleural Mesothelioma After Combined Modality Therapy

Who this might be right for
Malignant Pleural Mesothelioma
Sellas Life Sciences Group 41
Early research (Phase 1)Study completedNCT00821652
What this trial is testing

Randomized, Double Blind, Placebo-controlled Topical Resiquimod Adjuvant for NY-ESO-1 Protein Vaccination

Who this might be right for
Tumors
Nina Bhardwaj 26
Large-scale testing (Phase 3)Study completedNCT00645138
What this trial is testing

Comparison of Paravertebral Block With General Anesthesia in Patients Undergoing Breast Cancer Surgery

Who this might be right for
Breast Cancer
Weill Medical College of Cornell University 40
Testing effectiveness (Phase 2)Study completedNCT02210858
What this trial is testing

Tipifarnib in Treating Patients With Chronic Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or Undifferentiated Myeloproliferative Disorders

Who this might be right for
Accelerated Phase of DiseaseAtypical Chronic Myeloid Leukemia, BCR-ABL1 NegativeChronic Myelogenous Leukemia, BCR-ABL1 Positive+4 more
National Cancer Institute (NCI) 31
Testing effectiveness (Phase 2)Study completedNCT00615758
What this trial is testing

Erlotinib as 1st Line Treatment in NSCLC Stage IIIB/IV

Who this might be right for
Non Small Cell Lung Cancer
Hellenic Oncology Research Group 50
Not applicableEnded earlyNCT02067858
What this trial is testing

An Outcome Analysis for Stereotactic Body Radiation Therapy (SBRT) Treatment of Non-Small Lung Cancer Patients Using 4D PET/CT With Real-Time Position Management (RPM™) System and a Concomitant Evaluation of the Impact and Performance Characteristics of the Immobilization System

Who this might be right for
Non Small Cell Lung Cancer4D CT
Steven Burton 6
Not applicableStudy completedNCT00937248
What this trial is testing

Cone Beam Computed Tomography (CT) (CBCT) With and Without a Customized Vacuum Immobilization Device (CVID)

Who this might be right for
Rectal Cancer
University Health Network, Toronto 20
Early research (Phase 1)Active Not RecruitingNCT05717348
What this trial is testing

ES014 in Patients With Locally Advanced or Metastatic Solid Tumours

Who this might be right for
Solid TumorLocally Advanced Solid TumorMetastatic Solid Tumor
Elpiscience (Suzhou) Biopharma, Ltd. 120
Early research (Phase 1)Looking for participantsNCT06128148
What this trial is testing

Phase I Study of JYP0322 in ROS1 Fusion-Positive Solid Tumors

Who this might be right for
Protein Kinase InhibitorsOther Protocol Specified CriteriaLung Neoplasms+1 more
Guangzhou JOYO Pharma Co., Ltd 101
Early research (Phase 1)Study completedNCT02833155
What this trial is testing

Entinostat in Chinese Postmenopausal Women Patients With Locally Recurrent or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Taizhou EOC Pharma Co., Ltd. 19
Not applicableUnknownNCT06325826
What this trial is testing

The Study of the Validation of General Evaluation Score (GES) in the Prediction of Hepatocellular Carcinoma Risk Among Patients With Advanced Fibrosis and Cirrhosis Who Achieved Sustained Virological Response for Hepatitis C Virus After Direct Acting Antiviral Drugs

Who this might be right for
Hepatocellular Carcinoma
Egyptian Liver Hospital 500
Next Page
72